Skip to contentI
Insight Molecular Diagnostics Inc.
I
IMDXInsight Molecular Diagnostics Inc. Q3 2020 · 10-Q
Revenue$555.00K$555.00Kno prior Q3 2019 on file Net Income-$6.78M-$6.78MN/M vs Q3 2019 EPS Diluted-$0.10-$0.10N/M vs Q3 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
Operating Cash Flowderived-$6,005,000N/M Free Cash Flowderived-$6,531,000N/M Margins · derivedGross margin-8.3%
Operating margin-1125.0%
Net margin-1222.2%
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end